OR3O Dual Mobility
Device Recon Hips
PDI 00885556712252
General payments
$4,211,935
Research payments
$1,501,551
Through program year 2025, $4,211,935 in general payments and $1,501,551 in research payments were reported against OR3O Dual Mobility (Recon Hips).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $532,391 | 172 |
| 2025 | Research | $218,684 | 86 |
| 2024 | General | $1,054,527 | 1,718 |
| 2024 | Research | $424,404 | 75 |
| 2023 | General | $1,787,680 | 1,605 |
| 2023 | Research | $470,221 | 51 |
| 2022 | General | $837,337 | 1,162 |
| 2022 | Research | $388,241 | 47 |
Breakdown
The top 5 of 94 recipients; each share is of general payments naming this product in 2025.
The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 23 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
4,657 general · 259 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.